Senolytics reduce COVID-19 symptoms in preclinical studies ...Middle East

- News
Senolytics reduce COVID-19 symptoms in preclinical studies
Mayo Clinic researchers and colleagues at the University of Minnesota showed that COVID-19 exacerbates the damaging impact of senescent cells in the body. In preclinical studies, the senolytic drugs discovered at Mayo significantly reduced inflammation, illness, and mortality from COVID infection in older mice. The findings appear in the journal Science.

Hence then, the article about senolytics reduce covid 19 symptoms in preclinical studies was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Senolytics reduce COVID-19 symptoms in preclinical studies )

Apple Storegoogle play

Last updated :

Also on site :